Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Inari VISION Registry is a study that aims to collect information about devices and products made by Inari Medical, which are used to treat a condition called pulmonary embolism (a blockage in the lungs' blood vessels). This registry is open to patients worldwide who have received treatment with these devices. The study is currently recruiting participants who are at least 18 years old and can provide consent to take part in the registry. To join, patients must have already had treatment with an Inari Medical device and be within the enrollment period around their procedure.
Participants in this registry can expect to share their experiences and health outcomes after using the Inari devices. It’s important to know that people who are pregnant, breastfeeding, or involved in other studies that might interfere with this one cannot participate. The goal of this registry is to gather important data to help understand how well these devices work and to improve future treatments for pulmonary embolism.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Willing and able to provide informed consent per institution and geographical requirements
- • 2. Has received treatment with an eligible Inari Medical device. NOTE: If patients are consented prior to their procedure and the procedure does not take place, the patient will be considered a screen failure.
- • 3. Currently within enrollment window relative to their procedure
- • 4. Age ≥ 18 years
- Exclusion Criteria:
- • 1. Is or will be inaccessible for registry follow-up
- • 2. Meets exclusion criteria required by local requirements
- • 3. Current or planned participation in another drug or device study that, in the investigator's opinion, would interfere with participation in this registry
- • 4. Is pregnant or breastfeeding at the time of enrollment
About Inari Medical
Inari Medical is a pioneering medical device company focused on transforming the treatment of vascular diseases through innovative, minimally invasive solutions. With a commitment to advancing patient care, Inari specializes in developing technologies for the removal of thrombus and the restoration of blood flow, particularly in conditions such as deep vein thrombosis and pulmonary embolism. The company is dedicated to rigorous clinical research and development, ensuring that its products meet the highest standards of safety and efficacy. Inari Medical is at the forefront of enhancing procedural outcomes and improving quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Glasgow, , United Kingdom
London, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported